[Advanced Science] Investigators combined the anti-inflammatory small-molecule rosiglitazone with MSCs to construct a cell–drug conjugate using MSCs as cellular carriers. Rosiglitazone was encapsulated within nanoparticles coated with neutrophil membranes and anchored onto the MSC surface.